secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cabaletta Bio, Inc. (CABA)
CIK:        0001759138
Form:       8-K
Filed at:   2026-06-11T11:01:13+00:00
Accession:  0001759138-26-000033
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cabaletta Bio stockholders approve doubling authorized shares to 600M; re-elect directors
--------------------------------------------------------------------------------

- Authorized common stock increased from 300M to 600M shares (80.4M for, 1.8M against).
- Directors Scott Brun, M.D. and Shawn Tomasello, MBA re-elected as Class I directors to 3-year terms.
- Ratified Ernst & Young LLP as independent auditor for FY 2026 (82.1M for).
- Advisory say-on-pay passed with 27.5M for vs 26.0M against (broker non-votes 28.7M).
- Proposal 3 (Plan Amendment) was withdrawn by Board before the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759138/000175913826000033/0001759138-26-000033-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759138/000175913826000033/caba-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001759138-26-000033

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer